Earnings Summary

Dr. Reddy's Laboratories Ltd.’s revenue jumped 12.48% since last year same period to $70830Mn in the Q1 2024. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated -1.83% fall in its revenue since last 3-months.

Dr. Reddy's Laboratories Ltd.’s net profit jumped 36.26% since last year same period to $13070Mn in the Q1 2024. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated -5.21% fall in its net profits since last 3-months.

Dr. Reddy's Laboratories Ltd.’s net profit margin jumped 21.14% since last year same period to 18.45% in the Q1 2024. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated -3.45% fall in its net profit margins since last 3-months.

Dr. Reddy's Laboratories Ltd.’s price-to-earnings ratio after this Q1 2024 earnings stands at 20.23.

Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) estimates for the current quarter stand at 0.91 - a -98.67% fall from last quarter’s estimates.

Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) estimates for the current year stand at 0.91.

Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) jumped 11092.86% since last year same period to 78.35 in the Q1 2024. This indicates that the Dr. Reddy's Laboratories Ltd. has generated 11092.86% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Dr. Reddy's Laboratories Ltd.’s return on assets (ROA) stands at 0.12.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Dr. Reddy's Laboratories Ltd.’s return on equity (ROE) stands at 0.22.